Elanco Animal Health (ELAN) Tops Q1 EPS by 6c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts ELAN Hot Sheet
Join SI Premium – FREE
Elanco Animal Health (NYSE: ELAN) reported Q1 EPS of $0.40, $0.06 better than the analyst estimate of $0.34. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.28 billion.
GUIDANCE:
Elanco Animal Health sees FY2026 EPS of $1.03-$1.09, versus the consensus of $1.03. Elanco Animal Health sees FY2026 revenue of $5.01-5.085 billion, versus the consensus of $5 billion.
For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Helen of Troy rejects $37-per-share takeover bid from Spectrum Brands
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
